The Playground

How dangerous is CoV-19 especially Omicron?

A few day ago a had a positive lateral flow test. These tests are only positive if you have a significant virus load so its safer than a PCR test. But these tests miss about 50% of the early low load infections.

Here in Switzerland many people are sick but most of the time not positive. My brother had serious throat issues for more than 2 days but no Omciron.

What symptoms did I get? Record high (of this year...) temperature of 37.4C A little sour throat. Worst was a kind of headache and also thin stool. All symptoms known from Omicron.

Of course I started therapy already more than 2 days before testing positive. Nigella seeds you squeeze with the teeth and swallow the oil to disinfect the throat. Also basic for me is Sutherlandia and for 5 days Ivermectin.

To support throat and nose I prepared a little bit of Iodine solution that I did apply directly on the throat with long (15cm) medical cotton sticks.

So what was Omicron? Just a soft cold - thanks to treatment. I went out to do my garden work. I went to the shops to buy a new thermometer and some more Aspirin solution and of course food.

As said multiple times. Only fools die from CoV-19 or a COV-19 gene therapy = "fake vaccine".

One more upgrade for Omicron .BAx now .BA2/XE::

How did the omicron XE strain form and what is Japan's response? - The Mainichi

TOKYO -- As the BA.2 subvariant of the coronavirus's omicron variant replaces the BA.1 subvariant that became mainstream during Japan's sixth wave of

mainichi.jp

According to U.K. government documents, the XE variant was first reported in the U.K. on Jan. 19, and 1,125 cases have been confirmed in the country as of April 5. It has been reported there that the new coronavirus strain spreads 12.6% faster than BA.2, and the Japanese government plans to thoroughly quarantine and monitor such cases.

Israel:: https://datadashboard.health.gov.il/COVID-19/general

During the last 4 weeks about 93 boostered died and about 46 unvaxx. So overall there is no death protection for boostered. Of course if you look at age groups there always is a short time protection due to immune stimulation.

But as everywhere the data today is totally unreliable as we don't know who is recovered how many boosters at what time the dead did get etc...

In reality nobody should die from Omicron. But the JF-mafia of Israel obviously thinks it should go on with supporting the NAZI terror on their own people.

New Analysis Shows Fluvoxamine Has The Potential To Reduce Covid-19 Hospitalizations By More Than 90%

New Analysis Shows Fluvoxamine Has The Potential To Reduce Covid-19 Hospitalizations By More Than 90%

There is an ever-expanding need for SARS-CoV-2 antivirals. A recent analysis suggests fluvoxamine may greatly reduce the risk of hospitalization in Covid…

www.forbes.com

Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), originally designed to treat depression. A recent meta-analysis by Lee et al. reviews three clinical trials of fluvoxamine. Of the 19 trials Lee et al. found searching the World Health Organization trial database, ten were retained after filtering for duplicates. Of those ten, seven were excluded because they were either still recruiting, focusing on inpatient, suspended, or had not begun. The process left three trails of 2,196 outpatients. All three trials were placebo-controlled randomized trials with unvaccinated, symptomatic adults PCR-test confirmed to be infected with SARS-CoV-2. We note that all trials predate the Delta and Omicron variants. Between the three trials and over 2,000 outpatients, Lee et al. found that the overall probability of association with reduced hospitalization ranged from 94.1% to 98.6%.

no idea but thought you may like to know.

The system may be off a few..

From Wallace Thornhill...

I"m still stuck about perpetual motion constant creation of voltage

1. a state in which movement or action is or appears to be continuous and unceasing. "the planet is in perpetual motion"
   • the motion of a hypothetical machine which, once activated, would run forever unless subject to an external force or to wear. "the age-old quest for the secret of perpetual motion"
   • volcanic activity motion ect.
   • oil to a gas from cars ect from given areas and the gyro effect ect..expanding gasses blown away by the sun?
   • no idea but Interesting.

Quote from Wyttenbach

According to U.K. government documents, the XE variant was first reported in the U.K. on Jan. 19, and 1,125 cases have been confirmed in the country as of April 5. It has been reported there that the new coronavirus strain spreads 12.6% faster than BA.2, and the Japanese government plans to thoroughly quarantine and monitor such cases.

Recently watched a Dr. John Campbell video where he talked about new Omicron BA.2 variants : BA2.12 and BA2.12.1 found in New York and apparently in a few dozen countries. They may be 23 and 27 percent respectively more transmissible than BA.2 which is definitely a wow factor if true.

UVA Study: Rapid Decline in Pfizer Antibody Generation, Particularly Noticeable in High-Risk Elderly

UVA Study: Rapid Decline in Pfizer Antibody Generation, Particularly Noticeable in High-Risk Elderly

www.trialsitenews.com

University of Virginia Health (UVA) recently conducted a study tracking antibodies induced by both mRNA COVID-19 vaccines from Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) and found that the performance of the Moderna vaccines trumps that of Pfizer-BioNTech when measuring antibody response. For example, the antibodies generated by BNT162b2 rise more slowly while decline more rapidly than those generated by mRNA-1273. Moreover, the Pfizer vaccine is inferior to the Moderna vaccine when measuring the generation of antibodies in the elderly—the Pfizer-BioNTech vaccine generates fewer antibodies in the elderly—the most vulnerable—than young persons. This isn’t the case with the Moderna vaccine where age wasn’t relevant. While the UVA study team praises the vaccines, real-world performance problems become ever more apparent along with the good they have brought (reduction in severe disease and death), and an extraordinary number of safety reports are still disregarded by health authorities. A lead immunologist affiliated with UVA goes on the record that he was “struck how rapidly the antibodies fell after the mRNA vaccines, particularly the Pfizer-BioNTech vaccine.”

While both vaccines generated similar peak levels of COVID-19 fighting antibodies, the most recent UVA study results contradict other data, demonstrating that revealed antibodies were higher after Moderna. However, the discrepancy is likely explained by the waning Pfizer-BioNTech mRNA vaccine performance. UVA’s Newsroom declared, “It will be important for future research to consider the time frame from vaccination carefully when assessing antibody response.”

Investigator on the Record: Pfizer’s Inferior Antibody Performance

Benham Keshavarz, Ph.D., an immunologist with the UVA’s School of Medicine shared, “It’s not surprising that antibody levels fall after vaccination.” The immunologist and academic researcher continued, “But we were struck by how rapidly the antibodies fell after the mRNA vaccines, particularly the Pfizer/BioNTech vaccine.”

The Study

The UVA study team investigated post-vaccination antibody levels in 234 UVA employees across a 10-month duration. 114 of the participants received the BNT162b2 vaccine, and 114 received mRNA-1273, while six received Johnson and Johnson’s single-shot vaccine.

Results

In what could be seen as a bombshell finding, the UVA study team found that among the study participants those who received the Pfizer-BioNTech and the Moderna (mRNA vaccines), jabs had antibody levels 50 times higher than those among the Johnson and Johnson vaccine recipients. Yet quickly the levels of antibodies drop fast, with BNT162b2 dropping precipitously.

Six months out the poor performance of BNT162b2 was observed, as the Newsroom reports the “Pfizer vaccine recipients had antibody levels lower than both the Moderna recipients and patients who had been hospitalized with severe COVID-19 six months prior. (Patients who suffer severe COVID are thought to generate more antibodies than people who recover from mild cases.)”

Perhaps the differences in the similar mRNA-based vaccines suggest UVA are the result of “differences in their formulations and the amount of mRNA they contain. This could explain the differences in antibody response they generate. Time between doses also could be a significant factor.”

The researchers also noticed that there was a trend for men to generate fewer antibodies than did women, but, contrary to a prior report, this was ultimately deemed statistically insignificant.

The scientists note that it remains unclear if the greater antibody response generated by the Moderna vaccine translates into better real-world protection. But the study, they say, may help explain emerging differences in COVID-19 infection rates seen among recipients of the different vaccines.

Commentary

While antibodies are important, they are what UVA shared a “crude tool to assess vaccine effectiveness.” Even doctors are uncertain as to the correlation between antibodies and COVID-19 protection.

They further note that while antibodies decline, the immune system “remembers how to make the necessary antibodies when against confronted by the virus.” The UVA investigators report that all three vaccines investigated in the study “performed remarkably well in protecting against severe illness, hospitalization, and death.”

A Pathway to better Understanding

UVA reports that it will be important to better understand the nature of how and why antibody levels decline as this may help physicians and policymakers better assess when booster shots are needed. A disturbing finding, for example, the Pfizer-BioNTech vaccine generated fewer antibodies in the elderly, a high-risk group for more severe SARS-CoV-2 infection.

UVA was careful to not demean the vaccines in any way as Jeffrey Wilson, MD, Ph.D., study senior author declared, “Both Pfizer/BioNTech and Moderna have proven very effective in protecting against severe disease, but our study builds on others that have shown some subtle differences in outcomes that favor Modern.” He continued, “This could particularly be true in higher-risk populations, such as older subjects or those who have conditions with suppressed immune systems.”

UVA Research Published

The researchers have published their findings in the scientific journal Frontiers in Immunology. The research team consisted of Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Jaimin Patel, Lyndsey M. Muehling, Glenda Canderan, Deborah D. Murphy, Savannah G. Brovero, Samuel M. Ailsworth, Will H. Eschenbacher, Emily C. McGowan, Barbara J. Mann, Michael R. Nelson, Alexandra Kadl, Judith A. Woodfolk, Thomas A.E. Platts-Mills and Jeffrey M. Wilson. Platts-Mills and Wilson disclosed that they have received assay support from Thermo-Fisher/Phadia unrelated to the study. Wilson also has received consultancy fees from the company unrelated to the research.

Funding

The work was supported by UVA’s Manning COVID-19 Research Fund, a UVA School of Medicine GAP Award, an American Academy of Allergy, Asthma and Immunology Faculty Development Award, and National Institutes of Health grants R37-AI20565 and R21-AI160334

Generation IV, the future of nuclear power

Although nuclear power remains controversial, new reactors are being built in surprising numbers and these will provide the second largest share of the world’s…

newatlas.com

Today, the nuclear industry is in Generation III or III+. The first generation was marked by the prototype reactors of the late 1940s, '50s, and early '60s, and the second by the first commercial light water reactors from the mid-1960s to the mid-1990s. These were followed by Generation III, which are also light water reactors, but include new technology like more reliable fuels, passive cooling systems, and reactor cores that are less prone to failure. Generation III+, which will be built until the 2030s, are the latest reactors and are Generation III designs with additional improvements.

What comes next will be Generation IV...

Quote:

“We’re generation five,” Dr. Khim (President of Global Energy Corp) told the Variety during an exclusive interview, “and first of all this is a brand new concept.”

“You have to change the basic science of nuclear power,” Khim explained. “We’ve been working with the U.S. Navy for about 22 years and the basic science phase is now over. Now we’re going into commercial development...

Officials of the Navy on Guam, including Capt. John V. Heckmann Jr., CO of Naval Facilities and a professional engineer, attended the GEC briefing. The GEC board of directors, Khim says, includes some well-known Washington D.C. Players, including former Secretary of Defense Frank Carlucci, former Congressman and Secretary of Transportation Norman Mineta, and former U.S. Congressman Tom Davis, among others.” - end quotes

Quote from Fm1

For example, the antibodies generated by BNT162b2 rise more slowly while decline more rapidly than those generated by mRNA-1273.

Moderna outperforms Pfizer at least 5x. In reality even much more as Moderna's second RNA is not subject to change and always is somehow working.

Pfizer is a plain vanilla repurposed cancer gene tech chemo therapy (origin Bion-tech) with no vaccine effect. It's just immune stimulation.

Already the official data after 6 months of the phase III "Pfizer" "fake study" did show a higher mortality among the gene therapy group than the placebo group.

I hope all board members of US CDC go to jail for not stopping the Pfizer crap. This fake vaccine - overall - did not save a single live!

Look at India:: Treatment outperform gene therapy by about 1000x!

McCullough Questions the Assumption that the COVID-19 Vaccines can Eradicate the SARS-CoV-2 Virus while Continuing to Emphasize Early Treatment

McCullough Questions the Assumption that the COVID-19 Vaccines can Eradicate the SARS-CoV-2 Virus while Continuing to Emphasize Early Treatment

www.trialsitenews.com

Apr. 16, 2022, 2:00 p.m.

Cardiologist and epidemiologist Dr. Peter McCullough recently lectured on COVID-19 via the Optimist media platform. Held in the Bahamas, McCullough presented a lecture titled “COVID-19 Vaccine Safety and Efficacy and the Urgent Need for Early Ambulatory Treatment.” Considered a controversial figure by some in the mainstream and a hero by others following the COVID-19 early treatment movement, the key to the advancement of life sciences is scientific debate and even dissension at times for a diverse array of views and analyses to inform and advance the topic.

One of the first advocates for early treatment and expanded protocols using repurposed therapies as well as pharmaceuticals when available, McCullough was introduced as a “global phenomenon” by the conference host in the Bahamas at 32:15 Optimist Bahamas Live Stream - YouTube in the event published on YouTube.

The Texas-based, highly published cardiologist has created controversy as he hasn’t succumbed to a subordinated, passive role during the pandemic. He has paid with former employers, giving up a very comfortable upper-middle-class existence for taking what he believes is an important stand. A practicing internist and cardiologist, McCullough spends half the time seeing patients and the other half of his time as an investigator and author.

When COVID-19 hit Dr. McCullough was on a couple of task forces at the start of the pandemic and right away wanted to find ways to treat patients yet he found doctors seemed paralyzed probably based on fear of infection.

McCullough felt a dangerous precedent of not doing anything to care for the patient and the rest has been history. In this lecture, McCullough introduces some historical events.

For example, he introduced mass vaccination starting with the swine flu vaccination in 1976. A quarter of Americans were vaccinated and upon twenty-five deaths according to the doctor (ultimately 33) and the vaccine program was stopped. McCullough believes it is “unacceptable in American society” to give vaccines electively and have patients die. Of course, one could argue that the COVID-19 pandemic, the worst in a century, is markedly different from the Swine flu crisis in 1976 with over 1 million deaths in America alone.

TS News reviewed the incident. During this vaccination initiative by December 15, 1976, reported cases of Guillain-Barre syndrome (GBS) impacted vaccinated patients in at least ten states. On December 16, the government placed a one-month suspension of the vaccination program called by CDC Director David Sencer.

According to some sources, three people that received the vaccine died of heart attacks right after receiving the vaccine at the same Pittsburgh clinic sparking an investigation and recall of a particular vaccine batch. However, the CDC notably declared them not related to the vaccine. A BBC report emphasized at least three deaths and that the lessons learned from the Swine flu vaccination should be heeded during the COVID-19 pandemic.

A chronology of the Swine flu crisis acknowledged many more possible fatalities connected to the mass inoculation initiative—totaling 33 deaths of people after receiving the vaccines. Yet the government appeared to disagree with any connection to this day.

Writing for Slate Rebecca Onion reported that the swine flu mass vaccination debacle could be a factor that fueled a growing anti-vaccine movement.

The CDC’s William Foege reported that the incidence of GBS was 4-times as high in swine flu vaccinated people than those not receiving the Merck-produced vaccine. President Gerald Ford agreed with suspending the mass vaccination program while standing behind the decision to initiate the mass immunization program. The CDC’s Sencer was soon replaced by a new Secretary of Health, Education, and Welfare. And the immunization program was not reinstated. One must wonder if there were no deaths connected to the vaccine why wasn’t the program reinstated.

TS News suggests that discussing these challenging issues absolutely doesn’t make one “anti-vaccine”—this is often employed as a smear tactic used by political, economic, and ideological players and forces with a particular agenda to discredit a counterpoint of view often via ad hominem attacks.

This media for example is pro-vaccine and repeatedly reports on the fact that the current COVID-19 vaccines are helping to reduce hospitalization and death while we call out the challenge areas (e.g., potential durability issues and the concern that a high number of adverse events, although not acknowledged as associated with the products, may in fact be connected.

Mass Eradication of SARS-CoV-2 via Vaccination—A Dream?

McCullough suggests that many public health officials essentially “dream” of a vaccine that wipes out a pathogen as was the case with polio. However, McCullough argues that with SARS-CoV-2, the virus behind COVID-19 “the one thing I think we learned relatively quickly is it’s not like polio, it’s not an enterovirus in that we will not get to zero cases. So this idea of getting to zero cases is a fool's errand in my view. Because the virus is sufficiently contagious, it’s a respiratory virus; we don’t get to zero cases of flu, we don’t get to zero cases of pneumococcal pneumonia or zero cases of mycoplasma pneumonia so since when do we declare zero cases.”

McCullough thinks this assumption or paradigm comes from the brief public health experience with SARS-COV-1 involving China and some cities in Canada where it was around for 90 days and it kind of “burned itself out” declared the doctor. Thus, “we did get to zero cases’ because the body's immunity was so good,'' speculated the doctor.

Noting that SARS-CoV-1 came in and out in 90 days and McCullough suggested that perhaps public health officials and researchers came to the conclusion that for SARS-CoV-2 we are basically going to get into zero cases by locking down society, airplanes, and travel, or “put a lid on” and ultimately eradicate the pathogen till it’s all but gone.

While critical of this current batch of vaccines, McCullough is not an anti-vaxxer by any means, in fact for much of his career he has operated in the heart of mainstream medicine, often collaborating with industry as an investigator. Thus, while many that are in the mainstream today that align with the assumption that SARS-CoV-2 can be eradicated completely with the vaccine (this would be the impetus for vaccine mandates for example), a minority of critics, perhaps growing in numbers, suggest the vaccine should be used more in a targeted intervention for higher risk cohorts. Some others suggest avoiding usage, despite compelling data that the vaccines do protect from severe disease and death better than no vaccine.

Of course just because McCullough’s views don’t sync with the mainstream of medicine at this stage of the pandemic doesn’t mean that he is fully or partially incorrect in his analysis. Proper science advances due to intellectual conflict, debate, argument, even at times dissention. While McCullough could be incorrect, he could also be correct, even if just partially, and in fact, with the current vaccination track record, while this media believes that they (the COVID-19 vaccines) have helped reduce hospitalization and death, they haven’t fared nearly as well stopping disease transmission. This fact is on display across heavily immunized nations going through record surges of cases and in some places such as New Zealand and South Korea recently, deaths. Breakthrough infections, hospitalizations, and deaths are increasingly reported with mutating pathogens that better evade vaccine-induced antibodies.

TS News asks Is it possible for the line of critical physicians such as McCullough to find common ground among other physicians and researchers moving forward? Isn’t it time for a real, earnest, and honest debate on the facts, as uncomfortable as they may be, less the politics and vested interests? This means looking at the good and the challenges associated with the vaccines. That’s how science can truly advance. But perhaps there’s too much politics, ideology, and vested interests across all parties for any common ground? That would be unfortunate.

Follow the link to listen to the McCullough presentation—and remember, diversity of opinion and thought is vital to not only the advancement of science but also a healthy democracy.

Call to Action: Follow the link to the lecture at 32:15

.

• Andrea Rossi April 16, 2022 at 2:48 PM

  Yuri:

  Thank you for your attention to our work.

  Absolutely yes, and in the paper you cited I think it is explained why.

  Warm Regards,

  A.R.

• Yuri April 16, 2022 at 2:43 PM

  Dear Dr Andrea Rossi,

  Is it correct to say that the formation of electrons clusters in phase is the core of the theoretical system you hypothesised in

  http://www.researchgate.net/publication/330601653_E-Cat_SK_and_Iong_range_particle_interactions

  ?

  All the best,

  Yuri

• 
  
  Andrea Rossi April 16, 2022 at 3:06 AM

  Julian:

  Thank you for your pre-order.

  You can send copy of it to

  [email protected]

  and surely you will receive your receipt.

  Warm Regards,

  A.R.

• Julian April 16, 2022 at 3:03 AM

  Dear Dr Andrea Rossi,

  Thank you for the video of the presentation of the Ecat SKLep I watched on

  http://www.ecat.corn

  It is convincing.

  I made a pre-order using the form in the website, but did not receive the confirmation of receipt: what can I do to get it ?

  Best,

  Julian

• Andrea Rossi April 16, 2022 at 3:00 AM

  Anonymous:

  The amount of 1 mil units is necessary to make the price we offered.

  If we deliver before, even at higher price, we will be obliterated by the reverse engineering.

  Warm Regards,

  A.R.

• Anonymous April 16, 2022 at 2:57 AM

  Mr Rossi,

  Why is it necessary to reach orders for 1 million units before starting to deliver the Ecat SKLep ?

  I think that starting the delivery you will rapidly sell more than 1 million units.

  Anonymous

• Roberto April 16, 2022 at 2:50 AM

  @Levin E. Iniur

  I don’t think bitcoins are a good idea, their value could drop to zero anytime, because they are completely out of control. The bitcoins possessors can easily convert their cryptovalute into dollars and buy the Ecat,

  Roberto

• Andrea Rossi April 16, 2022 at 2:48 AM

  Levin E. Iniur:

  Thank you for the suggestion,

  Warm Regards,

  A.R.

.

Great song that’s for sure.

Rossi waiting for the millionth ECatSKLep order.

It’s like Linus waiting for the Great Pumpkin to rise out of the pumpkin patch on Halloween.

No matter how many years they wait, the Great Pumpkin never comes.

Sam, he ain’t coming, ever.

Well if he does not have the orders and product shipped this year.

Rossi will at least earn worst salesman of the year award.

Quote from sam12

Well if he does not have the orders and product shipped this year.

Rossi will at least earn worst salesman of the year award.

And he will win also the award as best charlatan.

@Notlaketrout

Have you ever built a crystal radio? Maybe you should. You could tell people it's your perpetual voltage device powering a small radio. The point here, if you're not getting it, is that a lot of different frequency energies are swirling around our heads. Those perpetual motion machines could be harvesting it.

Wouldn't it be funny if Rossi's device was really harvesting energy from a near by one hundred thousand watt radio station? Sort of the Casimir effect on steroids.

Quote from truth

And he will win also the award as best charlatan.

Hopefully, there is no one foolish enough to send this conman any $